title: [NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis].
authors.affiliation: Service d'Oncologie Médicale, Hôpital Avicenne, Bobigny, France. gaetan.des-guetz@wanadoo.fr
authors.forename: Gaëtan
authors.initials: G
authors.lastname: des Guetz
authors.forename: Robert
authors.initials: R
authors.lastname: Benamouzig
authors.forename: Stanislas
authors.initials: S
authors.lastname: Chaussade
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Breau
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D016021:Epidemiologic Studies; D006801:Humans; D010190:Pancreatic Neoplasms / Q000503:physiopathology* / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors